Significance of the RBD mutations in the SARS-CoV-2 Omicron: from spike opening to antibody escape and cell attachment
M. L. Hossen, P. Baral, T. Sharma, B. S. Gerstman, P. P. Chapagain
Abstract
We computationally investigated the role of the Omicron RBD mutations on its structure and interactions with ACE2. Our results suggest that, compared to the WT and Delta, the mutations in the Omicron RBD facilitate a more efficient RBD opening and ACE2 attachment. These effects, combined with antibody evasion, may contribute to its dominance over Delta. While the Omicron RBD escapes most antibodies from prior infections, epitope analysis shows that it harbors sequences with significantly improved antigenicity compared to other variants, suggesting more potent Omicron-specific neutralizing antibodies.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis of Omicron immune evasion: A comparative computational study of Spike protein-Antibody interaction.
D. Contractor, C. Globisch, … A. Jain·bioRxiv·Mar 15, 2022
- Effect of Delta and Omicron mutations on the RBD-SD1 do-main of the Spike protein in SARS-CoV-2 and the Omicron mutations on RBD-ACE2 interface complex
W.-Y. Ching, P. Adhikari, … R. Podgornik·bioRxiv·Jul 28, 2022
- Structural and computational insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
- The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta Variants: a computational approach
Prashant Ranjan, Neha Neha, … Parimal Kumar Das·Microbial PathogenesisPeer-reviewed·Jan 1, 2022
- Binding Interactions between RBD of Spike-Protein and Human ACE2 in Omicron variant
B. Jawad, P. Adhikari, … W.-Y. Ching·bioRxiv·Feb 10, 2022
- Structural insight into antibody evasion of SARS-CoV-2 omicron variant
Jyoti Kumar Verma, Naidu Subbarao·bioRxiv·Jan 25, 2022